seattle genetics | Seagen - Dedicated to revolutionizing cancer care

Keyword	CPC	PCC	Volume	Score	Length of keyword
seattle genetics	0.15	0.2	9996	15	16
seattle	1.84	0.6	7127	88	7
genetics	1.57	0.1	3057	50	8

Keyword	CPC	PCC	Volume	Score
seattle genetics	0.16	1	9997	71
seattle genetics stock	1.81	0.3	455	29
seattle genetics careers	0.45	0.4	5142	43
seattle genetics seagen	1.1	0.3	7865	97
seattle genetics stock news	1.86	0.7	3942	76
seattle genetics pfizer	1	0.1	9456	47
seattle genetics stock price	0.49	0.8	1586	75
seattle genetics news	0.38	0.4	5037	4
seattle genetics bothell wa	1.44	0.4	5431	17
seattle genetics cafepharma	1.6	0.1	7848	49
seattle genetics merger	1.82	0.1	136	32
seattle genetics website	0.61	0.5	1926	2
seattle genetics inc	1.33	0.3	164	41
seattle children's genetics	0.87	0.3	7764	53
seattle children's hospital genetics clinic	0.85	0.6	9039	53
biochemical genetics seattle children's	0.61	0.2	250	7
jason howard seattle genetics linkedin	0.16	0.7	4817	5

Search Results related to seattle genetics on Search Engine

Seagen - Dedicated to revolutionizing cancer care
seagen.com

https://www.seagen.com/

WebAs a pioneer in antibody-drug conjugates (ADCs), Seagen has led the way in novel cancer therapeutics for more than 20 years. We’re committed to discovering safe and effective solutions to challenging clinical needs. Today, our research efforts are dedicated to advancing a pipeline of innovative therapies for solid tumors and blood-related ...

DA: 63 PA: 18 MOZ Rank: 54

Seagen - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Seagen

WebSeagen Inc. (formerly Seattle Genetics, Inc.) is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody -based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington (a suburb of Seattle ), is the industry leader in antibody-drug conjugates or …

DA: 60 PA: 6 MOZ Rank: 98

Pfizer will acquire Seattle-area biotech giant Seagen for ... - GeekWire
geekwire.com

https://www.geekwire.com/2023/pfizer-will-acquire-seattle-area-biotech-giant-seagen-for-43-billion/

WebMar 13, 2023 · Seagen was previously known as Seattle Genetics when it launched back in 1998. It went public in 2001, pricing its IPO at $7 per share. The new deal values the company at approximately $229 per...

DA: 7 PA: 16 MOZ Rank: 22

Science and Research – Seagen
seagen.com

https://www.seagen.com/science

WebSeagen is an industry leader in innovative, targeted drug delivery. ADC technology harnesses the power of potent payloads and the specificity of antibodies to selectively deliver small molecule drugs to tumors. Our proprietary ADC technologies are designed to target cancer cells with greater precision, reducing side effects.

DA: 14 PA: 25 MOZ Rank: 8

Our History – Seagen
seagen.com

https://www.seagen.com/who-we-are/history

WebSeattle Genetics, Inc. changes its name to Seagen Inc. to reflect the transformation of the company from its Seattle roots into a global operation. 2021 TIVDAK® (tisotumab vedotin-tftv) receives accelerated approval in the U.S. – our fourth approved medicine.

DA: 15 PA: 45 MOZ Rank: 27

Pfizer buys Bothell-based Seagen for $43B | The Seattle Times
seattletimes.com

https://www.seattletimes.com/business/pfizer-will-spend-43-billion-to-acquire-seagen/

WebMar 13, 2023 · Pfizer is spending about $43 billion to acquire Seagen, the Bothell-based biotech giant formerly known as Seattle Genetics. Pfizer plans to let the cancer treatment developer “continue...

DA: 87 PA: 53 MOZ Rank: 83

Seattle Genetics, Inc. Announces Corporate Name Change to …
businesswire.com

https://www.businesswire.com/news/home/20201008005358/en/Seattle-Genetics-Inc.-Announces-Corporate-Name-Change-to-Seagen-Inc.

WebOct 8, 2020 · BOTHELL, Wash.-- ( BUSINESS WIRE )--Seagen Inc. is the new corporate name for Seattle Genetics, Inc. (Nasdaq:SGEN), a global biotechnology company dedicated to developing innovative cancer...

DA: 5 PA: 100 MOZ Rank: 62

Seattle Genetics gets $1 billion investment from Merck in cancer …
seattletimes.com

https://www.seattletimes.com/business/seattle-genetics-gets-1-billion-investment-from-merck-in-cancer-deal-potentially-worth-billions-more/

WebSep 14, 2020 · Seattle Genetics shares jumped $21.82, or 14.6%, to close Monday at $171.79. The companies will develop an experimental medicine, ladiratuzumab vedotin or LV, that has shown signs of early...

DA: 84 PA: 100 MOZ Rank: 47

Seattle Genetics takes a new identity | The Seattle Times
seattletimes.com

https://www.seattletimes.com/business/technology/seattle-genetics-takes-a-new-identity/

WebOct 8, 2020 · Technology. Seattle Genetics takes a new identity. Oct. 8, 2020 at 3:12 pm Updated Oct. 8, 2020 at 5:27 pm. By. Seattle Times business staff. After more than two decades that saw it become...

DA: 90 PA: 87 MOZ Rank: 83

Seattle Genetics wins another speedy approval as FDA clears …
biopharmadive.com

https://www.biopharmadive.com/news/seattle-genetics-fda-approval-breast-cancer-tucatinib/576311/

WebApr 17, 2020 · The Food and Drug Administration on Friday approved Seattle Genetics’ drug Tukysa as a treatment for patients whose advanced breast cancer expresses the HER2 protein and has spread to other areas of the body, including the brain.

DA: 31 PA: 11 MOZ Rank: 18